Page 345 - ASHG 2012 Annual Meeting Program Guide

332
SPEAKER AND AUTHOR DISCLOSURES
Requa, M., BioNano Genomics, Inc - 3 (3649)
Richard, G., GeneDx - 3 (2579)
Richards, S., Life Technologies - 15; Receive
discounted reagents and share data (Session 3)
Rieder, M. J., Adaptive Biotechnologies - 1, 3 (530)
Riley-Gillis, B., Hoffmann-La Roche - 3 (1252)
Roberts, J. S., 23andMe - 12; Pathway Genomics - 12
(
Session 9)
Rodríguez-Santiago, B., Quantitative Medicine
Laboratories - 3 (3208)
Rogan, P. K., Cytognomix - 10 (3672)
Romano-Silva, M., FAPEMIG: CBB-APQ-00075-09 - 2;
CNPq 573646/2008-2 - 2 (2385)
Romero, J. A., Life Technologies - 3 (3708)
Roos, F., Agilent Technologies - 3 (3685)
Rosenfeld, J. A., Signature Genomic Laboratories,
PerkinElmer, Inc. - 3 (274)
Russell, A., Omicia, Inc. - 1, 3, 4 (3602)
Ruvolo, M., Agilent Technologies - 3 (975)
Sá, M. J. N., Harvard Medical School Portugal
Program - Junior Award - 2; Fundação para a
Ciência e Tecnologia - 2 (3122)
Saisanit, S., Roche Pharmaceuticals - 3 (3580)
Schiffmann, R., Amicus Therapeutics - 2, 3, 5;
Progrnosys, Biosciences, Inc - 3; Shire Human
Genetic Therapies - 2, 5 (1684)
Schmidt, J. L., NIHDS/NIH - 2; American Academy of
Neurology - 2; BDF Newlife and National Institutes for
Health Research - 2; USPTO - 3; patent pending (2452)
Schwartz, S., Laboratory Corporation of America - 3 (949)
Scott, C. R., Genzyme Corporation - 5 (727)
Segal, M. M., SimulConsult - 3, 4, 10, 13 (3581)
Sidow, A., DNAnexus - 1, 5 (397)
Sikela, J. M., GATC Science LLC - 4, 7, 10, 13
(
Session 22)
Siklosi, K. R., Cystic Fibrosis Foundation - 2 (1731)
Smaoui, N., GeneDx - 3 (1765)
Snyder, M. W., Ariosa Diagnostics - 11; Stratos
Genomics - 11; Good Start Genetics - 11; Adaptive
TCR - 11 (94)
Soler, C. V., CINAPCE Program, Campinas, Brazil -
12 (2233)
Song, K., Ariosa Diagnostics - 1, 3 (3020)
Spritz, R. A., Pfizer - 15; Spouse full-time employee
of Pfizer, Inc. (Session 80)
Srinivasan, A., Verinata Health, Inc. - 3 (3021)
Stuenkel, A. J., Ambry Genetics - 1, 3 (1767)
Superko, H. R., Celera Corporation, Alameda, CA., - 3;
Medco Research Institute, LLC/an Express Scripts
Company, Bethesda, MD - 1, 3; Ariosa Diagnostics
Inc. - 3 (1714)
Swaroop, A., University of Michigan - 7, 10 (Session 7)
Syed, F., Illumina - 3 (3718)
Talkowski, M. E., Signature Genomic Laboratories,
PerkinElmer, Inc - 3 (68)
Tang, M., Sequenom CMM - 3; Sequenom Inc - 1 (3023)
Tanzi, R. E., Prana Biotechnology - 1, 5 (Session 10)
Tavares, P., CGC Genetics - 13 (1778)
Tavtigian, S. V., Myriad Genetics, Inc. - 7, 10 (1783)
Taylor, J., Ariosa Diagnostics - 5 (2989)
Taylor, J. C., LifeTechnologies - 12; Johnson &
Johnson - 12; AstraZeneca - 12 (133)
Thompson, J., Nabsys - 1, 3, 4, 10, 13 (3703)
Thomson, N., CLC bio - 1, 3 (3662)
Torchia, B., Signature Genomic Laboratories,
PerkinElmer, Inc., Spokane,WA - 3 (902)
Uhl, G., Duke University - 10 (2541)
Umbarger, M. A., Good Start Genetics - 1, 3, 10 (3693)
Utz, J., Genzyme - 2; Actelion, Shire - 5; Actelion,
Shire, BioMarin, Genzyme - 8 (1855)
Vaidya, D., Excet Inc - 5 (1710)
Vaidyanathan, R., Epicentre (an illumina Company) - 3;
Illumina - 3 (585)
van der Valk, R. J. P., GlaxoSmithKline - 2 (2168)
Vasenkova, I. A., Kailos Genetics Inc. - 3 (3687)
Velasco, H., National University - 3 (703)
Visitacion, M. R., Agilent Technologies, Inc - 3 (3709)
Voorhoeve, E., Signature Genomics Laboratories - 3
(98)
Wang, L.-S., Johnson & Johnson Pharm Res & Dev -
2 (342)
Wang, X., Fluidigm Corp. - 1, 3 (3619)
Watts, G. S., Ion Torrent - 9 (3712)
Wernig, M., Fate Therapeutics - 7, 10; Stem Cells Inc. -
11 (
Session 78)
Westbrook, J., Locus Development, Inc. - 1, 3 (1771)
White, M., Hypogen - 1, 4, 11, 13 (245)
Whitley, C. B., Shire Human Genetic Therapies - 2, 5,
11, 12, 14 (801)
Wisotzkey, R., NextBio - 3 (1190)
Woo, C., Life Technologies - 3 (3520)
Woo, S., Korean Coral Resources Bank, Ministry of
Land Transport Mari - 2; Korea Ocean Research and
Development Institute - 2 (3673)
Wu, S., 23andMe, Inc. - 1 (2149)
Xie, P., Merck - 2; Eli Lilly and Co - 5; GlaxoSmithKline
- 5;
Alkermes - 5 (2621)
Xue, Z., GlaxoSmithKline - 1, 2, 3 (651)
Yamasaki, M., Central Research Laboratory, Hitachi
Ltd, Tokyo, Japan - 12 (2496)
Yim, P. W., Life Technologies - 3 (486)
Zeng, W., Ambry Genetics - 3 (2698)
Zhan, Y., Affymetrix - 1, 3 (1582)
Zhang, Z., UMDF - 6 (534)
Zhao, Z., MolecularMD - 5; GlaxoSmithKline - 11;
Millennium Pharmaceuticals - 11; Illumina - 5 (136)
Zhong, J., Roche - 3 (242)
Ziegler, A., Affymetrix - 12 (1443)
Zimran, A., Protalix Biotherapeutics - 1, 5, 11, 14;
Shire Human Genetic Therapies - 8, 14 (788)